Shelf life (days): 365.0
Formulation: 50 or 100 µl of protein A-affinity purified recombinant monoclonal antibody
Clone Designation: 7B4G10G8
Target specificity: H1N1, H7N9 (A/Anhui/1/2013), H7N9 (A/Shanghai/1/2013)
Cross Reactivity: + Nucleocapsid protein; - Insect cell lysate
Formula Weight: 0.0
Notes: Influenza A nucleoprotein is a viral protein encoded by the NP gene in influenza A RNA.{69202} It is composed of an RNA-binding domain, oligomerization domains, and polymerase binding domains, and contains two nuclear localization signals and a cytoplasmic accumulation signal, which interacts with host actin.{69203,69204} Influenza A nucleoprotein packages the viral RNA into a helical ribonucleoprotein (RNP) complex that is a template for viral replication. Influenza A is a causative agent of seasonal flu, an acute upper respiratory infection characterized by many symptoms, including fever, dry cough, sore throat, body aches, and a runny nose and can lead to life-threatening complications in individuals with high-risk medical conditions.{69205} Cayman’s Influenza A Nucleoprotein Monoclonal Antibody (Clone 7B4G10G8) can be used for ELISA and Western blot (WB) applications. This recombinant antibody recognizes nucleoprotein at 53-56 kDa from H1N1 and H7N9.
Deutsch
English
